IMpower010: results from Asian patients in a phase 3 study of adjuvant atezolizumab in resected stage IB-IIIA NSCLC Kenmotsu, H., Zhou, C., Altorki, N., Felip, E., Vallieres, E., Sugawara, S., Sakai, H., Saito, H., Tao, M., Kawaguchi, K., Liu, Y., Yu, C., Wu, Q., Lin, H., Wu, F., Bennett, E., Mcnally, V., Gitlitz, B., Wakelee, H. ELSEVIER. 2022: S464

View details for DOI 10.1016/j.annonc.2022.05.063

View details for Web of Science ID 000834940400148